|
|
Article: Cancer Vaccine Pioneer at NYU to Review Personalized Cancer Vaccines, Pioneering Biotherapies Are at Advanced Trials Stage
- Article from:
- U.S. Newswire
- Article date:
- January 25, 2001
CopyrightCopyright 2001 U.S. Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
News Advisory:
Dr. Larry W. Kwak, M.D., Ph.D., senior investigator at the
National Institutes of Health, will present published findings
related to work on personalized cancer vaccine technologies, at 1
p.m. on Jan. 26 at The New York University Medical Center (NYU).
Specifically, Dr. Kwak will discuss pioneering advances in the field
of tumor-specific personalized cancer vaccines, to treat a variety
of lethal cancers.
As one example, on Sept. 27, 1999, the National Cancer Institute
(NCI) announced that, for the first time ever, results of a Phase II
cancer vaccine study demonstrated an anti-tumor effect in a small
group of patients vaccinated over a five-year period. NCI
researchers ...